• Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Average Recommendation of "Moderate Buy" by Brokerages

    Source: Buzz FX / 23 Nov 2024 03:01:08   America/New_York


    Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Average Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat November 23, 2024 Share Link copied to clipboard. Shares of Allogene Therapeutics, Inc.
    Read more...
Share on,